Population frequencies of HLA-DR–restricted mHags
| . | Immunogenic . | Nonimmunogenic . | ||
|---|---|---|---|---|
| +/+ . | +/− . | −/− . | ||
| LB-MR1-1R | 2 | 23 | 75 | |
| LB-PTK2B-1T | 21 | 49 | 30 | |
| LB-LY75-1K | 3 | 30 | 67 | |
| LB-MTHFD1-1Q | 20 | 48 | 32 | |
| . | Immunogenic . | Nonimmunogenic . | ||
|---|---|---|---|---|
| +/+ . | +/− . | −/− . | ||
| LB-MR1-1R | 2 | 23 | 75 | |
| LB-PTK2B-1T | 21 | 49 | 30 | |
| LB-LY75-1K | 3 | 30 | 67 | |
| LB-MTHFD1-1Q | 20 | 48 | 32 | |
Genotyping was performed for SNP rs2236410 (LB-MR1-1R), rs751019 (LB-PTK2B-1T), rs12692566 (LB-LY75-1K), and rs2236225 (LB-MTHFD1-1Q) in 1400 patient and donor samples. Frequencies (%) of homozygous-positive (+/+), heterozygous (+/−), and homozygous-negative (−/−) samples are shown.